Detailed answers about DR ANDREA CACERES MEDICAL SERVICES LIMITED, including incorporation, status, business activity, and accounts information.
When was DR ANDREA CACERES MEDICAL SERVICES LIMITED founded?
DR ANDREA CACERES MEDICAL SERVICES LIMITED was officially incorporated on 7 May 2026 and is registered under company number 17204168. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is DR ANDREA CACERES MEDICAL SERVICES LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of DR ANDREA CACERES MEDICAL SERVICES LIMITED?
DR ANDREA CACERES MEDICAL SERVICES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does DR ANDREA CACERES MEDICAL SERVICES LIMITED do?
DR ANDREA CACERES MEDICAL SERVICES LIMITED operates in the following sectors: 86210 - General medical practice activities, 86220 - Specialists medical practice activities. These SIC codes provide insight into the company's business activities and industry focus.
What is DR ANDREA CACERES MEDICAL SERVICES LIMITED's registered address?
The registered office address of DR ANDREA CACERES MEDICAL SERVICES LIMITED is 106 Cuddra Road, St Austell, Cornwall, England, PL25 3GB. This is the official address filed with Companies House for legal and statutory correspondence.
Is DR ANDREA CACERES MEDICAL SERVICES LIMITED financially stable?
Financial accounts for DR ANDREA CACERES MEDICAL SERVICES LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.